BullishAgent BullishAgent SEC Filings Economic Calendar Earnings Calendar Analyst Ratings IPOs Insiders Institutional Funds Screener
Sign in Register

BNTX

BioNTech SE NASDAQ
Healthcare ·Biotechnology ·DE · biontech.de
$99.35
After hrs $95.19 -0.32%
Mkt Cap $25.0B
52w Low $79.52 44.6% of range 52w High $124.00
50d MA $97.65 200d MA $102.61
P/E (TTM) -21.6x
EV/EBITDA -47.5x
P/B 1.2x
Debt/Equity 0.0x
ROE
P/FCF 72.6x
RSI (14)
ATR (14)
Beta 1.59
50d MA $97.65
200d MA $102.61
Avg Volume 1.1M
About
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV+ head and neck cancers; …
Recent Earnings
Date Time Est Rptd Surp Base Gap% D1% D2% D3% D4% D5% Guide ▲★
Mar 10, 2026 BMO -0.22 -0.38 -72.7% 83.89 +2.8% +8.3% +8.3% +7.4% +8.7% +7.9%
Nov 3, 2025 BMO -1.12 -0.14 +87.5% 103.96 +0.4% +0.8% +0.8% -0.5% -0.6% -0.8%
Aug 4, 2025 BMO -2.69 -1.82 +32.3% 110.03 +1.0% +0.9% +0.9% +1.2% +1.2% +1.5%
May 5, 2025 BMO -2.48 -1.82 +26.5% 101.10 -0.3% -6.3% -6.3% -8.2% -6.3% -8.2%
Mar 10, 2025 BMO 0.46 1.15 +148.7% 105.35 -1.7% -6.6% -6.6% -4.8% -7.5% -5.6%
Nov 4, 2024 BMO -1.74 0.89 +151.1% 108.97 -0.1% +1.8% +1.8% -2.1% -1.0% +1.5%
Aug 5, 2024 BMO -2.19 -3.62 -65.2% 78.36 +0.3% +1.5% +1.5% +1.1% +2.8% +3.1%
May 6, 2024 BMO -1.34 -1.42 -5.9% 93.35 -0.5% -2.6% -2.6% -3.4% -1.4% -1.8%
Mar 20, 2024 BMO 2.62 2.05 -21.8% 90.00 -0.5% +2.2% +2.2% +2.0% +3.3% +1.9%
Nov 6, 2023 BMO -0.62 0.73 +217.0% 99.71 -0.4% +2.7% +2.7% -0.1% -0.4% -0.2%
Recent Analyst Ratings
Date Firm Action Grade Target Base Open Gap% D1% D2% D3% D4% D5%
Apr 27 HC Wainwright & Co. Maintains Buy → Buy $105.46 $105.59 +0.1% -3.2% -3.2% -3.7% -1.9% -7.5%
Apr 10 Morgan Stanley Maintains Overweight → Overweight $91.98 $92.75 +0.8% +3.8% +5.1% +7.0% +8.1% +11.0%
Mar 31 HC Wainwright & Co. Maintains Buy → Buy $85.25 $86.29 +1.2% +4.3% +4.9% +7.0% +7.1% +5.1%
Mar 11 Morgan Stanley Maintains Overweight → Overweight $83.89 $86.28 +2.8% +8.3% +7.4% +8.7% +7.9% +13.1%
Mar 11 Canaccord Genuity Maintains Buy → Buy $83.89 $86.28 +2.8% +8.3% +7.4% +8.7% +7.9% +13.1%
Mar 11 BMO Capital Maintains Outperform → Outperform $83.89 $86.28 +2.8% +8.3% +7.4% +8.7% +7.9% +13.1%
Mar 11 TD Cowen Maintains Hold → Hold $83.89 $86.28 +2.8% +8.3% +7.4% +8.7% +7.9% +13.1%
Mar 11 Citigroup Maintains Buy → Buy $83.89 $86.28 +2.8% +8.3% +7.4% +8.7% +7.9% +13.1%
Mar 10 Jefferies Maintains Buy → Buy $102.16 $82.81 -18.9% -17.9% -11.1% -11.8% -10.7% -11.4%
Jan 16 Goldman Sachs Upgrade Neutral → Buy $106.07 $109.24 +3.0% +2.8% -0.5% +11.2% +11.7% +9.3%
Data updated apr 26, 2026 9:56am · Source: massive.com